KS

Kuldeep Singh

Active Director Director DIN 07531442
DIN 07531442 First appointment Jun 2016 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Kuldeep Singh

Data last updated:

Kuldeep Singh is a Director at Biosyndrome Ayurveda Private Limited (since 2016). The company operates in Chemicals.

DIN 07531442
Primary Designation Director
Industry Chemicals
First Appointment 20 Jun 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biosyndrome Ayurveda Private Limited U24234HR2016PTC064643
Director20 Jun 20162016Active

Board colleagues of Kuldeep Singh

NameDINCompanyDesignation
Lakhmi Chand07531401Biosyndrome Ayurveda Private LimitedDirector

Directorship timeline

Open interactive timeline →
Biosyndrome Ayurveda Private Limited
Premium access

Shareholding and investment profile for Kuldeep Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kuldeep Singh

Kuldeep Singh currently holds 1 directorship: Biosyndrome Ayurveda Private Limited (Director, since 20 Jun 2016).

Kuldeep Singh was first appointed on 20 Jun 2016 as Director at Biosyndrome Ayurveda Private Limited.

The current boards of Kuldeep Singh's companies include Lakhmi Chand (Biosyndrome Ayurveda Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available